These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 188727)

  • 21. In vitro correlates of cell-mediated immunity to experimental and human leukemia.
    Herberman RB
    Bibl Haematol; 1975 Oct; (43):260-4. PubMed ID: 183682
    [No Abstract]   [Full Text] [Related]  

  • 22. Cellular immune reactions in human acute leukemia.
    Herberman RB
    Hamatol Bluttransfus; 1974; 14():107-18. PubMed ID: 4615044
    [No Abstract]   [Full Text] [Related]  

  • 23. New looks in leukemia.
    Leventhal BG
    Cancer; 1975 Mar; 35(3 suppl):1015-21. PubMed ID: 234296
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Specificity of 51Cr-release cytotoxicity of lymphocytes immune to murine sarcoma virus.
    Herberman RB; Aoki T; Nunn M; Lavrin DH; Soares N; Gazdar A; Holden H; Chang KS
    J Natl Cancer Inst; 1974 Oct; 53(4):1103-11. PubMed ID: 4139276
    [No Abstract]   [Full Text] [Related]  

  • 25. In vitro depression of cellular immunity by Friend virus leukemic spleen cells.
    Toy ST; Whellock EF
    Cell Immunol; 1975 May; 17(1):57-73. PubMed ID: 1168547
    [No Abstract]   [Full Text] [Related]  

  • 26. Expression of antigens coded in murine leukemia viruses on thymocytes of allogeneic donor origin in AKR mice following syngeneic or allogeneic bone marrow transplantation.
    Wustrow TP; Good RA
    Cancer Res; 1985 Dec; 45(12 Pt 1):6428-35. PubMed ID: 2998600
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunotherapy in leukemia. Experimental and clinical approaches.
    Mathé G
    Ser Haematol; 1972; 5(5):66-86. PubMed ID: 4151467
    [No Abstract]   [Full Text] [Related]  

  • 28. Activation of specific cellular immunity toward murine leukemia in mice rejecting syngeneic somatic hybrid cells.
    Liang W; Cohen EP
    J Immunol; 1977 Sep; 119(3):1054-60. PubMed ID: 302270
    [No Abstract]   [Full Text] [Related]  

  • 29. Resistance to cellular immune response in AKR leukemias.
    Schäfer A; Schmidt W
    Eur J Immunol; 1986 Jul; 16(7):753-9. PubMed ID: 2424771
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies of the mechanisms for the induction of in vivo tumor immunity. III. Recruitment of host helper cells by donor T cells in adoptive transfer of cell-mediated immunity.
    Ting CC; Rodrigues D; Igarashi T
    J Immunol; 1979 Apr; 122(4):1510-8. PubMed ID: 221575
    [No Abstract]   [Full Text] [Related]  

  • 31. In vitro induction of cell-mediated immunity against tumor cells by antigen-fed macrophages.
    Treves AJ
    Immunol Rev; 1978; 40():205-26. PubMed ID: 223969
    [No Abstract]   [Full Text] [Related]  

  • 32. Studies of the mechanisms for the induction of in vivo tumor immunity. I. Induction of primary and secondary cell-mediated cytotoxic responses by adoptive transfer of lymphocytes.
    Ting CC
    Cell Immunol; 1976 Nov; 27(1):71-81. PubMed ID: 136303
    [No Abstract]   [Full Text] [Related]  

  • 33. Specific T cell-dependent, antigen-antibody mediated suppression of macrophages: abrogation by nonspecifically stimulated T cells.
    Rao VS; Mokyr MB; Gershon RK; Mitchell MS
    J Immunol; 1977 Jun; 118(6):2117-24. PubMed ID: 325141
    [No Abstract]   [Full Text] [Related]  

  • 34. Antiviral antibodies inhibit the lysis of tumour cells by anti-H--2 sera.
    Henning R; Schrader JW; Edelman GM
    Nature; 1976 Oct; 263(5579):689-91. PubMed ID: 185524
    [No Abstract]   [Full Text] [Related]  

  • 35. The immune response to primary Moloney sarcoma virus tumors in BALB-c mice: cellular and humoral activity of long-term regressors.
    Lamon EW; Anderson B; Wigzell H; Fenyö EM; Klein E
    Int J Cancer; 1974 Jan; 13(1):91-104. PubMed ID: 4594340
    [No Abstract]   [Full Text] [Related]  

  • 36. Cell mediated immunity in mice immunized with modified syngeneic gross lymphoma antigen.
    Almquist SJ; Eaton MD
    Cell Immunol; 1978 May; 37(2):383-9. PubMed ID: 657285
    [No Abstract]   [Full Text] [Related]  

  • 37. Suppression of Gross leukemia cell-surface antigens: a kind of antigenic modulation.
    Aoki T; Johnson PA
    J Natl Cancer Inst; 1972 Jul; 49(1):183-92. PubMed ID: 5037434
    [No Abstract]   [Full Text] [Related]  

  • 38. [On the effectivity in vitro of heterologous rabbit antisera against mouse leukemia cells (author's transl)].
    Milleck J
    Arch Geschwulstforsch; 1973; 42(4):274-84. PubMed ID: 4138846
    [No Abstract]   [Full Text] [Related]  

  • 39. Immunologic mechanisms in the prevention and therapy of cancer.
    Fleisher TA; Kersey JH
    Am J Dis Child; 1974 Nov; 128(5):739-42. PubMed ID: 4608684
    [No Abstract]   [Full Text] [Related]  

  • 40. Cancer active immunotherapy. Immunoprophylaxis and immunorestoration. An introduction.
    Mathé G
    Recent Results Cancer Res; 1976; 55():1-402. PubMed ID: 1087040
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.